Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
QNRX · NASDAQ · Pharmaceutical Preparations
Quoin Pharmaceuticals (QNRX) · oqro.io/stocks/QNRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.28−0.0791 (−2.35%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Integrated Core Strategies (US) LLC cut its QNRX stake below 5% (5.0%)Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
StemPoint Capital LP now owns 9.9% of QNRX as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 7, 2026
Ikarian Capital, LLC cut its QNRX stake below 5% (4.4%)SourceInsider trade · Traded Dec 23, 2024 · Filed Dec 27, 2024
CEO purchased ~$250K of QNRX shares in the open marketSourceInsider trade · Traded Dec 23, 2024 · Filed Dec 27, 2024
Director purchased ~$250K of QNRX shares in the open marketSourceInsider trade · Traded Dec 23, 2024 · Filed Dec 27, 2024
CFO purchased ~$55K of QNRX shares in the open marketSourceInsider trade · Traded Dec 23, 2024 · Filed Dec 27, 2024
Director purchased ~$45K of QNRX shares in the open marketSource